Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial

详细信息    查看全文

• 作者：Yaeko Kondo ; Norio Harada ; Akihiro Hamasaki…
• 关键词：Clinical trial ; Type 2 diabetes ; Insulin secretion ; DPP ; 4 inhibitor ; Sulphonylurea
• 刊名：Diabetology and Metabolic Syndrome
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：8
• 期：1
• 全文大小：928 KB
• 刊物主题：Diabetes; Metabolic Diseases; Endocrinology;
• 出版者：BioMed Central
• ISSN：1758-5996

文摘

Background The 52-week monotherapy with the dipeptidyl peptidase-4 inhibitor sitagliptin and the sulphonylurea glimepiride on early-phase insulin secretion in Japanese patients with type 2 diabetes mellitus (T2DM) is not known.